EverSource Wealth Advisors, LLC
- SEC CIK
- 0001710537
- Latest filing
- Jul 24, 2026
CLDX holding history
Celldex Therapeutics, Inc. in every 13F filed by EverSource Wealth Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CLDX overviewAll 13F holders of CLDXFull Q2 2026 holdings
- Shares (Q2 2026)
- 377
- Value
- $14.0K
- % of portfolio
- <0.1%
- Quarters held
- 11
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 377 | $14.0K | <0.1% | −105−21.8% | Reduced | Holders |
| Q1 2026 | 482 | $15.3K | <0.1% | +218+82.6% | Added | Holders |
| Q4 2025 | 264 | $7.17K | <0.1% | +2+0.8% | Added | Holders |
| Q3 2025 | 262 | $6.78K | <0.1% | +91+53.2% | Added | Holders |
| Q2 2025 | 171 | $3.48K | <0.1% | −1,267−88.1% | Reduced | Holders |
| Q1 2025 | 1,438 | $26.1K | <0.1% | +153+11.9% | Added | Holders |
| Q4 2024 | 1,285 | $32.5K | <0.1% | +878+215.7% | Added | Holders |
| Q3 2024 | 407 | $13.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 407 | $15.5K | <0.1% | −11−2.6% | Reduced | Holders |
| Q1 2024 | 418 | $15.6K | <0.1% | +379+971.8% | Added | Holders |
| Q4 2023 | 39 | $1.55K | <0.1% | +39 | New | Holders |